Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas
Clinical trial NCT07407803 · RECRUITING
Trial details
- NCT number
- NCT07407803
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2027-12-01
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.